Research
Supportive supervision has been found to be more effective than corrective fault-oriented inspections. Uganda’s Ministry of Health in 2012 implemented a comprehensive strategy (SPARS) to build medicines manage...
Journal of Pharmaceutical Policy and Practice 2017 10:33
Published on: 11 October 2017
Review
The UK Pharmaceutical Industry is arguably one of the most important industries to consider in the negotiations following the Brexit vote. Providing tens of thousands of jobs and billions in tax revenue and re...
Journal of Pharmaceutical Policy and Practice 2017 10:32
Published on: 4 October 2017
Research
High drug spending is a concern for policy makers due to limits on access for patients. Numerous policies have been proposed to address high drug spending. The existence of multifarious proposals makes it diff...
Journal of Pharmaceutical Policy and Practice 2017 10:31
Published on: 2 October 2017
Research
Despite making great progress in reducing under five mortality in the last three decades. Uganda still ranks high among countries with the highest under five mortality rates. More than a third (36%) of these d...
Journal of Pharmaceutical Policy and Practice 2017 10:30
Published on: 21 September 2017
Research
Opioids are widely prescribed for chronic non cancer pain (CNCP). Controlled substance agreements (CSAs) are intended to increase adherence and mitigate risk with opioid prescribing. We evaluated the demograp...
Journal of Pharmaceutical Policy and Practice 2017 10:29
Published on: 12 September 2017
Research
Different methods in pharmacoepidemiology can be used to study hypnotic use in children. But neither questionnaire-based data nor prescription records can be considered a “gold standard”. This study aimed to i...
Journal of Pharmaceutical Policy and Practice 2017 10:28
Published on: 8 September 2017
Letter to the Editor
Journal of Pharmaceutical Policy and Practice 2017 10:27
Published on: 5 September 2017
Research
The importance of creating and sustaining a strong culture of patient safety has been recognized as a critical component of safe medication use. This study aims to assess changes in attitudes toward patient sa...
Journal of Pharmaceutical Policy and Practice 2017 10:26
Published on: 5 September 2017
Research
Prescribing errors at the time of hospital discharge are common and could potentially lead to avoidable patient harm, especially when they involve insulin, a high-risk medicine widely used for the treatment of...
Journal of Pharmaceutical Policy and Practice 2017 10:25
Published on: 22 August 2017
Research
Babies are increasingly being exposed to antibiotics intrapartum in the bid to reduce neonatal and maternal deaths. Intrapartum antibiotic exposure, including even those considered safe in pregnancy, have been...
Journal of Pharmaceutical Policy and Practice 2017 10:24
Published on: 9 August 2017
Research
Reports from drug utilization reviews are important tools employed in the assessment of healthcare practices. The objective of this study was to evaluate drug utilization patterns among elderly hospitalized pa...
Journal of Pharmaceutical Policy and Practice 2017 10:23
Published on: 4 August 2017
Commentary
Despite pharmaceutical sciences being a core component of pharmacy curricula, few published studies have focussed on innovative methodologies to teach the content. This commentary identifies imaging techniques...
Journal of Pharmaceutical Policy and Practice 2017 10:22
Published on: 17 July 2017
Research
The private retail drug shops market in Bangladesh is largely unregulated and unaccountable, giving rise to irrational use of drugs and high Out-of-pocket expenditure on health. These shops are served by sales...
Journal of Pharmaceutical Policy and Practice 2017 10:21
Published on: 11 July 2017
Review
Smoking is the number one cause of preventable morbidity and mortality globally and although many countries have invested heavily in smoking cessation programs, 21% of the global population still smoke. Post c...
Journal of Pharmaceutical Policy and Practice 2017 10:20
Published on: 11 July 2017
Review
The challenge of providing access to high-priced patented medicines is a global problem affecting all countries. A decade and a half ago the use of flexibilities contained in the World Trade Organization Agree...
Journal of Pharmaceutical Policy and Practice 2017 10:19
Published on: 28 June 2017
Research
Barriers to expanding access to medicines include weak pharmaceutical sector governance, lack of transparency and accountability, inadequate attention to social services on the political agenda, and financing ...
Journal of Pharmaceutical Policy and Practice 2017 10:18
Published on: 2 June 2017
Research
Many middle-income countries are scaling up health insurance schemes to provide financial protection and access to affordable medicines to poor and uninsured populations. Although there is a wealth of evidence...
Journal of Pharmaceutical Policy and Practice 2017 10:17
Published on: 16 May 2017
Research
Medicines use related challenges such as inadequate adherence, high levels of antimicrobial resistance and preventable adverse drug reactions have underscored the need to incorporate pharmaceutical services to...
Journal of Pharmaceutical Policy and Practice 2017 10:16
Published on: 8 May 2017
Research
The Affordable Medicines Facility for malaria (AMFm) Program was a subsidy aimed at artemisinin-based combination therapies (ACTs) in order to increase availability, affordability, and market share of ACTs in ...
Journal of Pharmaceutical Policy and Practice 2017 10:15
Published on: 28 April 2017
Research
The purpose of this study is to explore medication-related perceptions of adult patients with type 2 diabetes attending treatment in public hospitals of urban centers in central Ethiopia.
Journal of Pharmaceutical Policy and Practice 2017 10:14
Published on: 8 April 2017
Research
The inappropriate use of antimicrobials is a problem worldwide. To target future interventions, a thorough understanding of the reasons behind this current behaviour is needed. Within the EU, the culture of an...
Journal of Pharmaceutical Policy and Practice 2017 10:13
Published on: 4 April 2017
Policy analysis
This article aims to highlight the positions of the Food and Drug Administration and the European Medicines Agency regarding use and marketing of hydroxyethyl starch (HES) products, and how these have changed ...
Journal of Pharmaceutical Policy and Practice 2017 10:12
Published on: 21 March 2017
Policy Analysis
It is essential to allocate available resources equitably in order to ensure accessibility and affordability of essential medicines, especially in less fortunate nations with limited health funding. Currently,...
Journal of Pharmaceutical Policy and Practice 2017 10:11
Published on: 27 February 2017
Commentary
When patients are told that standard medical treatment options have been exhausted, their treating physicians may start looking for promising new drugs that are not yet approved, and still under investigation....
Journal of Pharmaceutical Policy and Practice 2017 10:10
Published on: 21 February 2017
Research
Lack of regulatory capacity limits the conduct of ethical and rigorous trials of herbal medicines in developing countries. Sharing ethical and regulatory experiences of successful herbal trials may accelerate ...
Journal of Pharmaceutical Policy and Practice 2017 10:9
Published on: 20 February 2017
